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Gene Expression Profile during Chondrogenesis in Human Bone 
Marrow derived Mesenchymal Stem Cells using a cDNA 
Microarray
Mesenchymal stem cells (MSCs) have the capacity to proliferate and differentiate into 
multiple connective tissue lineages, which include cartilage, bone, and fat. Cartilage 
differentiation and chondrocyte maturation are required for normal skeletal development, 
but the intracellular pathways regulating this process remain largely unclear. This study was 
designed to identify novel genes that might help clarify the molecular mechanisms of 
chondrogenesis. Chondrogenesis was induced by culturing human bone marrow (BM) 
derived MSCs in micromass pellets in the presence of defined medium for 3, 7, 14 or 21 
days. Several genes regulated during chondrogenesis were then identified by reverse 
transcriptase-polymerase chain reaction (RT-PCR). Using an ABI microarray system, we 
determined the differential gene expression profiles of differentiated chondrocytes and 
BM-MSCs. Normalization of this data resulted in the identification of 1,486 differentially 
expressed genes. To verify gene expression profiles determined by microarray analysis, the 
expression levels of 10 genes with high fold changes were confirmed by RT-PCR. Gene 
expression patterns of 9 genes (Hrad6B, annexinA2, BMP-7, contactin-1, peroxiredoxin-1, 
heat shock transcription factor-2, synaptotagmin IV, serotonin receptor-7, Axl) in RT-PCR 
were similar to the microarray gene expression patterns. These findings provide novel 
information concerning genes involved in the chondrogenesis of human BM-MSCs. 
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INTRODUCTION
Mesenchymal stem cells (MSCs) are present in a variety of tis-
sues during human development, and in particular, are preva-
lent in adult bone marrow (1). MSCs isolated from bone mar-
row (BM) and expanded in vitro in their undifferentiated phe-
notype, retain an extensive capacity for multi-lineage differenti-
ation into chondrocytes, adipocytes, osteoblasts, and tenocytes 
under appropriate environmental cues (2). The presence of spe-
cific, distinct antigens identified by the monoclonal antibodies 
SH2, SH3, and SH4, on the surfaces of marrow-derived MSCs, 
that are not present on osteocytes and osteoblasts, suggests that 
these epitopes are developmentally regulated. The antigen which 
bound to SH2 antibody was identified as endoglin (CD105), a 
receptor for TGF-β3, which potentially plays a role in mediating 
the chondrogenic differentiation of MSCs and in their interac-
tions with hematopoietic cells (3). 
  Chondrogenesis, the differentiation of MSCs into chondro-
cytes, is crucial required for skeletal development and matura-
tion, since the cartilage anlage is the model for bone formation. 
Cartilage development thus includes the differentiation of MSCs 
into chondrocytes, followed by their maturation, and eventual 
their hypertrophy and death (4). Differential gene expression 
profiling has been widely performed to identify and character-
ize candidate genes that play potentially important roles in par-
ticular biological process (5).
  Although the amount of information regarding the role of 
growth factors and cytokines as inducers and mediators of MSC 
differentiation continues to increase, little is known about the 
gene expression profiling of MSC chondrogenic differentiation. 
In this study, we employed ABI GeneChips (representing > 30,000 
genes) to identify genes differentially expressed during BM-MSC 
chondrogenesis. ABI is introduced technology based on nylon-
spotted 60 mer oligonucleotides, that uses on oligomers to de-
tect each gene for most genes, chemiluminescence to measure 
gene expression levels, and fluorescence to grid to normalize 
and identify microarray features. The ABI gene list was compiled 
from information in public and Celera databases (6). This study 
was designed to identify differential gene expression profiles 
and novel genes that might be involved in BM-MSC chondro-
genesis. 
   Yoo HJ, et al.  •  Gene Expression during Chondrogenesis in Mesenchymal Stem Cells 
852   http://jkms.org DOI: 10.3346/jkms.2011.26.7.851
MATERIALS AND METHODS
Cell culture
Mononuclear cells from BM aspirates were isolated by density 
Ficoll-Paque gradient separation. BM was placed in a 50 mL sy-
ringe containing 5,000 units of preservative-free heparin, diluted 
1:1 with phosphate buffered saline (PBS), resuspended in PBS 
to a final volume of 10 mL, and layered over an equal volume of 
Histopaque-1,077 (Sigma Chemical Co., St. Louis, MO, USA). 
After centrifugation at 2,000 rpm for 30 min, mononuclear cells 
were recovered from the gradient interface, rinsed twice in PBS, 
adjusted to a concentration of 1.5 × 10
7 cells/10 mL, and seeded 
onto 100-mm culture plates in Dulbecco’s Modified Eagle’s Me-
dium-Low Glucose (DMEM-LG; 1 g/L glucose, JBI, Seoul, Korea) 
containing 1% penicillin-streptomycin (P/S; 10,000 units/mL, 
Gibco/BRL, New York, NY, USA) and 10% (v/v) heat-inactivated 
fetal bovine serum (FBS; Hyclone, Logan, UT, USA). Total num-
bers of nucleated and viable cells were determined using a he-
mocytometer and trypan blue (Gibco/BRL, Gaithersburg, MD, 
USA) staining. Cells were incubated at 37°C in a humidified 5% 
CO2 atmosphere and allowed to adhere for 72 hr. Non-adherent 
cells were then removed. The medium was changed twice a week. 
When cells were 80%-90% confluent, adherent cells were tryp-
sinized (0.05% trypsin, Gibco/BRL) at 37°C for 5 min and re-
plated in 100-mm culture plates. After passage 3, a morphologi-
cally homogenous population of adherent cells was obtained. 
During this expansion, medium was changed every 4-5 days.
 
Immunofluorescence staining
MSCs that adhered to spot slide bottoms were fixed with -20°C 
methanol (100%) for 5 min. Cells were then rehydrated in PBS 
for 5 min at room temperature, washed three times with PBS, 
blocked with 3% bovine serum albumin in PBS, and incubated 
overnight at 4°C with SH2 (American Type Culture Collection 
[ATCC], Rockville, VA, USA) as a positive control. Primary anti-
body (SH2) was removed by washing three times with PBS, and 
cells were then incubated with fluorescein isothiocyanate (FITC)-
labeled affinity-purified antibody to mouse IgG + IgM (H + L) 
(DiNonA Inc., Seoul, Korea) for 1 hr at room temperature. Sec-
ondary antibodies were removed by washing three times with 
PBS. Coverslips were mounted onto slides with a solution con-
taining 50% PBS and 50% glycerol. Labeled cells were observed 
under an Axiovert 200 (Zeiss, Thornwood, NY, USA).
Flow cytometry
Flow cytometry was performed to determine MSCs positive for 
SH2. Cells were permeabilized with ice cold 75% methanol in 
PBS for 30 min at 4°C, and washed three times. A FITC-conju-
gated SH2 antibody (DiNonA), diluted 1:500 in PBS, was then 
added, and cells were incubated for 1 hr at 4°C. Cells were ana-
lyzed within 2 hr of staining using a flow cytometer (FACScali-
bur, Becton Dickinson, Bedford, MA, USA). A total of 1 × 10
6 cells 
were collected for each measurement. Negative control samples 
were stained with an isotype-matched irrelevant mAb. 
In vitro chondrogenesis
To induce chondrogenic differentiation, 200,000 MSCs were 
placed in a 15-mL polypropylene tube and centrifuged at 1,000 
rpm for 5 min. Pellets were then cultured at 37°C in 5% CO2 and 
300 μL of serum-free chondrogenic medium consisting of Dul-
becco’s modified Eagle medium-high glucose (DMEM-HG, JBI) 
supplemented with 10 ng/mL of transforming growth factor-β3 
(TGF-β3, R&D Systems, Minneapolis, MN, USA), 100 nM dexa-
methasone (Sigma-Aldrich, St. Louis, MO, USA), 50 μg/mL ascor-
bate-2-phosphate, 100 μg/mL pyruvate, and 50 mg/mL ITS + 
Premix (Becton Dickinson Biosciences, Bedford, MA, USA; 6.25 
μg/mL insulin, 6.25 μg/mL transferrin, 6.25 ng/mL selenious 
acid, 1.25 mg/mL bovine serum albumin [BSA], and 5.35 mg/
mL linolenic acid); the medium was replaced every 2-3 days for 
3, 7, 14, or 21 days.
  
RNA preparation 
Total RNA was extracted from undifferentiated MSCs and from 
pellets after 3, 7, 14, or 21 days of differentiation using RNeasy 
kits (Qiagen, Valencia, CA, USA), according to the manufactur-
er’s instructions. And 1,200 μL of RLT buffer supplemented with 
beta-mercaptoethanol (10 μL/mL) was added to the washed 
cells. RNA integrity was assessed by gel electrophoresis and RT-
PCR and concentrations were determined by measuring absor-
bance at 260 nm.
Microarray
Total RNA was processed using the Genesys Applied Biosystem 
Facility (Genesys, Munster, Germany), according to manufactur-
er’s recommendations. Each RNA pool (2 μg) was labeled with 
Digoxigenin-UTP using the ABI Chemiluminescent RT-IVT La-
beling Kit v 1.0. Double-stranded cDNA was prepared from total 
RNA. UTP-digoxigenin-labeled complementary RNA (cRNA) 
was synthesized by in vitro transcription. Labeled cRNA (10 μg) 
was hybridized to ABI Human Genome Survey Microarray v 2.0, 
which was then incubated with alkaline phosphatase-linked 
digoxigenin antibody. Phosphatase activity was then initiated 
to produce the chemiluminescent signal. Chemiluminescent 
(cRNA) and fluorescent (spot background) signals of the cRNA 
and standard control spots were then scanned. Chemilumines-
cent detection and image acquisition was performed using an 
Applied Biosystems 1,700 (AB1,700) Chemiluminescent Micro-
arrays Analyzer, according to the manufacturer’s instructions. 
Using the software supplied with the AB1,700 apparatus, the spot 
chemiluminescent signal was normalized over the fluorescent 
signal of the same spot to obtain normalized signal value. For 
inter-array normalization, global median normalization was ap-Yoo HJ, et al.  •  Gene Expression during Chondrogenesis in Mesenchymal Stem Cells 
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plied across all microarrays (7).
Data analysis
Data analysis and data normalization were performed using the 
method described by Quackenbush (8). For background cor-
rection, the mean intensities of areas surrounding spots were 
subtracted from spot intensities (local area background). Data 
sets were normalized by dividing the mean intensity value of 
every spot (in duplicate) by sum of all spot intensities within a 
sample to eliminate experimental or data acquisition variations. 
Normalized data were used to calculate the gene expression level 
ratios of different culture stages. A two-fold expression cut-off 
was applied. For hierarchical gene cluster analysis, expression 
ratios were calculated for all genes as described by Eisen et al. (9).
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
First strand cDNA was synthesized using reverse transcriptase 
(RT) and 1 μg of total RNA. Reactions were conducted in 20 μL 
of buffer containing; 0.5 μL oligo (dT)12-18 primer (Gibco/BRL, 
Grand Island, NY, USA), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 
3 mM MgCl2, 40 mM DTT, 0.5 mM deoxynucleotide triphosphate 
(dNTP) mixture (Invitrogen, Carlsbad, CA, USA), 10 unit RNase 
inhibitor (Gibco/BRL), and 200 units of MMLV reverse transcrip-
tase (Invitrogen). After incubation at 37°C for 60 min, reactions 
were stopped by heating at 70°C for 15 min. To remove remain-
ing RNA, 1 μL of E. coli RNase H (4 mg/mL) was added to reac-
tion mixtures and incubated at 37°C for 30 min. cDNAs obtained 
were used as a template for PCR amplification using gene-spe-
cific primers for target genes and for glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). Primer sequences are listed in Table 1.
  PCR amplification of cDNA was performed in an automated 
thermal cycler (GeneAmp PCR System 2,400, Applied Biosys-
tems, Foster City, CA, USA), in a final volume of 25 μL contain-
ing; 4 μL of cDNA solution, 20 mM Tris-HCl (pH 8.4), 50 mM 
KCl, 1.5 mM MgCl2, 0.1% Triton X-100, 0.2 mM dNTP mixture, 
0.4 pM of each primer, and 5 units of Taq DNA polymerase (Pro-
mega, Madison, WI, USA). After PCR, amplified products were 
analyzed by electrophoresis in 1.5% agarose gel and visualized 
by ethidium bromide staining under UV light illumination. 
 
RESULTS
Cultures of human MSCs and their phenotypes 
The in vitro growth pattern of MSC is shown in Fig. 1. Human 
bone marrow-derived MSCs were cultured and expanded. Dur-
Table 1. Selected genes and their RT-PCR primer sequences
Gene                            Primer sequences
Hrad 6B F: 5´- TCC AAA TAA ACC ACC AAC TG -3´
R: 5´- GGA CTG TTA GGA TTC GGT TC -3´
Annexin A2 F: 5´- CAT TCT GAC TAA CCG CAG CA -3´
R: 5´- CGG TTA ATC TCC TGC AGC TC -3´
BMP-7 F: 5´- CCT ACC CCT ACA AGG CCG TCT TC -3´
R: 5´- TGC TCC CCG TGG ACC GGA TGC TG -3´ 
Contactin-1 F: 5´- CAA TAG TGC AGG GTG TGG AC -3´
R: 5´- TGG CTA GGA GGT GCT TTC TT -3´
Peroxiredoxin-1 F: 5´- ATG TCT TCA GAG TGC AAA AAT TG -3´ 
R: 5´- TCA CTT CTG TTA GCG AAA TAC TCT -3´
Heat shock transcription 
   factor-2
F: 5´- GAA GAA CCT GTT TCA GCA CAT AGT C -3´
R: 5´- GAT GTT ATG ATT CAA AAT GGA ATC CAT C -3´
Synaptotagmin IV F: 5´- GCG GGA TCC GTG CAC GTG CTT AAA GGA G -3´
R: 5´- GCG GAA TTC CTC TTG ATG ATC TCT CTG G -3´
Serotonin receptor-7 F: 5´- ATC GGC TCC ATC CTG ACG CTC AT -3´ 
R: 5´- CCA AAG TCC TGG CTG ATC AAG CA -3´
Axl F: 5´- GAG GAT GAA CAG GAT GAC TGG -3´
R: 5´- ACG AAG GTC TGA TGT CCC AGA -3´
IL-15 F: 5´- CAC ATT TGA GAA GTA TTT CCA TCC AGT GC -3´
R: 5´- CAT CCT AGC AAA CAA CAG TTT GTC TTC -3´ 
F, forward primer; R, reverse primer.
Fig. 1. Schematic representation of the experimental procedure (A) and growth curve of bone marrow derived mesenchymal stem cells (BM-MSCs) in culture (B). Increases in 
the numbers of viable adherent cells during incubation were measured by counting trypan blue negative cells. Cultures were started at 5,000 cells per well, harvested daily for 
10 days, and numbers of adherent cells were counted. Data represent mean cell numbers ± SD of three experiments performed in duplicate. BM, bone marrow; RBC, red blood 
cell; QC, quality control.
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ing the log phase of growth, cells proliferated with a population 
doubling time of 30 hr, and this growth period was followed by 
a confluent growth-arrested phase.
  Colonies were examined approximately 7 days after initial plat-
ing. A morphologically homogeneous population of 90% con-
fluent fibroblast-like cells was obtained after 2 weeks. The cells 
were replated into culture dishes and cultured for 2 weeks. The 
replated cells were used for subsequent experiments. The cul-
tured MSCs were positive for SH2 by flow cytometry (Fig. 2).
Time course of BM-MSC chondrogenesis 
MSCs were pelleted into micromasses and differentiated in se-
rum-free medium in the presence of TGF-β3 and dexametha-
sone. Immediately after centrifugation, the cells appeared as 
flattened pellets at the bottom of tubes. One day later, pellets 
had a thickened lip, and between days 2 and 3, pellet became 
spherical without any increase in size. Pellets then grew in size 
and pellet diameters increased to about 2-fold on days 7 and 14 
(Fig. 3A).
Microarray data
Using normalized microarray data, we identified 1,486 differen-
tially expressed genes (Fig. 4A), which included 1,303, 121, 40, 
20, and 2 genes exhibiting minimum 2 to < 5, 5 to < 10, 10 to < 20, 
20 to < 70 and > 70-fold changes, respectively. To verify gene ex-
pression profiles determined by microarray analysis, the expres-
sion levels of 10 genes with high fold changes (2-48 fold chang-
es, Table 2) were confirmed by RT-PCR.
Confirmation of gene expression by RT-PCR 
The expression levels of the 10 genes selected (Hrad 6B, annexin 
A2, BMP-7, contactin-1, peroxiredoxin-1, heat shock transcrip-
tion factor-2, synaptotagmin IV, serotonin receptor-7, Axl, and 
IL-15) were analyzed by RT-PCR, by using total RNAs obtained 
Fig. 2. Human bone marrow derived mesenchymal stem cells (BM-MSCs) confirmation by morphology, immunofluorescence staining, and flow cytometry. (A) BM-MSCs show a 
spindle-shaped fibroblastic morphology after culture expansion under the phase contrast microscope. Original magnification × 100. (B) Cultured BM-MSCs are positive for SH2 
by immunofluorescence staining. (C) Flow cytometric analysis of BM-MSCs for the expression of SH2.
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Fig. 3. Histochemical analyses of undifferentiated and differentiated human mesen-
chymal stem cells (MSCs). (A) Time course of MSC chondrogenesis. Macro picture of 
a differentiating MSC pellet on days 0, 3, 7, 14, and 21. A 1-mm rule is included. (B) 
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days of differentiation).
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Fig. 4. Gene expressions of microarray and reverse transcriptase-polymerase chain 
reaction (RT-PCR). (A) Two-way hierarchical clustering of 1,486 genes expressed by 
undifferentiated (con) and differentiating (at 3, 7, 14, and 21 days) bone marrow de-
rived mesenchymal stem cells. Expression profiles were clustered by average linkage 
hierarchical clustering. The color scale of standardized signal intensities in the micro-
array extends from bright green (down-regulation) to bright red (up-regulation). (B) RT-
PCR analysis of 10 selected genes in undifferentiated (con) and differentiating stem 
cells (at 3, 7, 14, and 21 days). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was used as an internal control. Yoo HJ, et al.  •  Gene Expression during Chondrogenesis in Mesenchymal Stem Cells 
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from 5 samples (Fig. 4B). The expression levels of 9 genes (Hrad 
6B, annexin A2, BMP-7, contactin-1, peroxiredoxin-1, heat shock 
transcription factor-2, synaptotagmin IV, serotonin receptor-7, 
Axl) were low in undifferentiated cells and increased in differ-
entiated cells by RT-PCR and microarray, but the expression pat-
tern of IL-15 was different. Expression level of IL-15 tended to 
be decreased in microarray, but increased in RT-PCR (Fig. 5).
 
DISCUSSION
In this study, we determined gene expression profiles in differ-
entiated chondrocytes and BM-MSCs. The microarray technol-
ogy used did not allow quantitative comparisons between the 
expressional levels of different genes, but did allow us to com-
pare fold changes with time and quantify differences in the ex-
pressions of multiple genes. Our results show the sequences for 
gene expressional changes during BM-MSC chondrogenesis. 
Microarray data showed that Axl, synaptotagmin IV, Hrad6B, 
peroxiredoxin-1, BMP-7, heat shock transcription factor-2, an-
nexin A2, contactin-1 and serotonin receptor-7 expressions were 
maintained in differentiating BM-MSCs until day 14.
  Axl is overexpressed in a number of tumors (10), and IL-15 is 
known to mediate the transactivation and upregulation of Axl 
with subsequent activation of PI3K/Akt and upregulations of 
Bcl-2 and Bcl-XL (11). On the other hand, synaptotagmin IV is 
required for the maturation of secretory granules in PC12 cells 
(12). Human homologues of yeast Rad 6 (Hrad6B) encode ubiq-
uitin-conjugating enzymes, and is highly expressed in lung can-
cer cell. It has been reported that DNA repair and UV mutagen-
esis are defective in Saccharomyces cerevisiae rad6 mutant (13). 
Peroxiredoxin-1 is the most ubiquitously expressed member of 
the peroxiredoxin family, and is found in the cytoplasm, nucle-
us, mitochondria, and peroxisomes of many cell types (14). Fur-
thermore, recent studies have reported high levels of peroxiredox-
in-1 expression in the bovine bladder, seminal vesicles, testes, 
adrenal gland (15), and in the rat liver, skin, lungs and nervous 
system (14). The role of peroxiredoxin-1 in cell differentiation 
and proliferation suggests that it has a possible role in growth 
and development. 
  Recent studies have confirmed that BMP-7 is a strong chemo-
tactic component in cartilage cells produced by mesenchymal 
stem cells, and it can promote cartilage cells to secrete specific 
extracellular matrix (proteoglycans and collagen type II). And 
BMP-7 can induce the differentiation of BM-MSCs into cartilage 
cells, and that it offers a greater efficiency in repairing cartilage 
and subchondral bone defects (16).
  Heat shock transcription factor-2 (HSF-2) has been shown to 
be a transcriptional regulator of heat shock protein gene expres-
sion during the differentiation and development of eukaryotic 
cells in a tissue dependent manner (17). HSF-2 plays an impor-
tant role in FGF-2 stimulated osteoclast formation, and HSF-2 
deficiency was found to modulate gene expression in stromal/
preosteoblast cells and affect osteoclastogenesis in the bone mi-
croenvironment (18). Annexins bind to negatively charged phos-
Table 2. Identification of genes differentially expressed during chondrogenesis
Reporter ID Reporter name Fold
114958 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) 48.93291
171467 nudix (nucleoside diphosphate linked moiety X)-type motif 8 40.41234
166535 heat shock transcription factor 2 39.17662
143528 tubulin, beta 1 37.39376
162651 hypothetical protein DT1P1A10 22.14788
195022 tumor suppressor candidate 3 21.78559
148565 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19 kDa 20.83195
186773 FLJ45224 protein; prostaglandin D2 synthase 21kDa (brain) 19.24891
202455 peroxiredoxin 1 18.53505
173923 fibronectin type 3 and ankyrin repeat domains 1 18.25457
160161 chromosome 6 open reading frame 210 17.19068
183606 FLJ22624 protein 16.76164
112057 ubiquitin-conjugating enzyme E2B (RAD6 homolog)  6.96857
144159 RYK receptor-like tyrosine kinase  6.29185
143111 glutamic pyruvate transaminase (alanine aminotransferase) 2 4.28248
142438 polymerase (DNA-directed), delta interacting protein 2  3.97053
209540 annexin A2  3.29699
177636 bone morphogenetic protein 7 (osteogenic protein 1)  3.27800
148029 NAD(P) dependent steroid dehydrogenase-like  3.26781
131216 BH3 interacting domain death agonist  2.72827
123506  gamma-aminobutyric acid (GABA) A receptor, beta 1  2.51372
139212 synaptotagmin IV  2.49410
136701 mannan-binding lectin serine protease 2  2.42219
136002 signal transducer and activator of transcription 1, 91 kDa  2.02504
This listed genes were selected from the most highly fold changed genes (2-48 fold).Yoo HJ, et al.  •  Gene Expression during Chondrogenesis in Mesenchymal Stem Cells 
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pholipids in a Ca
2+-dependent manner and have a conserved 
structure. The human annexin, annexin A2 (alternative names: 
annexin II, p36, and lipocortin II) is expressed abundantly in var-
ious human organs, including the placenta, lungs, heart, and 
liver (19). At the cellular level, annexin A2 is expressed on endo-
thelial cell surfaces and acts as a co-receptor for plasminogen 
and tissue plasminogen activator (20). Furthermore, annexins 
are commonly dysregulated in cancer (21) and annexin A2 is 
upregulated in a variety of tumors and cancer cell lines (22, 23). 
Contactin-1 is a cell surface adhesion molecule, which is normal-
ly expressed by neurons, oligodendrocytes, and human astro-
cytic gliomas (24, 25). Previous studies have reported that MSCs 
express IL-15, essential hematopoietic growth factor (26, 27) and 
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Fig. 5. Comparisons of Axl, synaptotagmin IV, Hrad 6B, peroxiredoxin-1, BMP-7, heat shock transcription fac-
tor-2, annexin A2, contactin-1, IL-15 and serotonin receptor-7 gene expression patterns as determined by micro-
array and RT-PCR analysis. The x-axis indicates the five time points (differentiation days 0, 3, 7, 14 and 21), and 
the y-axis represents fold changes determined by microarray and RT-PCR analysis.
IL-15 is also a potent apoptosis inhibitor and has many immu-
nomodulatory activities (28). The Serotonin receptor 7 is the most 
recently identified member of the serotonin receptor family and 
is found in brain, mainly in the hypothalamus, thalamus, hippo-
campus, and cortex (29).
  In the present study, we performed microarray analysis dur-
ing BM-MSC chondrogenesis in vitro. We found that over 1,486 
genes were expressed by BM-MSCs during chondrogenesis, and 
we identified genes that were differentially expressed. These data 
may provide novel information of the genes involved in chon-
drogenesis of human BM-MSCs. Yoo HJ, et al.  •  Gene Expression during Chondrogenesis in Mesenchymal Stem Cells 
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Mesenchymal stem cells (MSCs) have the capacity to proliferate and differentiate into multiple connective tissue lineages such as 
cartilage and bone. In this study, using an ABI microarray system, the authors determined the differential gene expression profiles 
of differentiated chondrocytes and bone marrow (BM)-MSCs. Normalization of this data resulted in the identification of 1,486 
differentially expressed genes. To verify gene expression profiles of microarray, RT-PCR was also performed. Gene expression 
patterns of 9 genes in RT-PCR were similar to the microarray results. These findings provide novel information concerning genes 
involved in the chondrogenesis of human BM-MSCs.